Additional benefits ofSGLT2i therapy in patients with acute decompensated heart failure and central sleep apnea.

14 March 2025 (17:20 - 18:20)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Assistant Professor Petar Kalaydzhiev

University Hospital Tsaritsa Yoanna, Sofia (Bulgaria)

8 More presentations in this session

Presentation thumbnail

Clinical determinants and long-term survival in heart failure with supra-normal ejection fraction. Insights from LECRA-HF registry.

Doctor K. Stepien (Krakow, PL)

Abstract Slides

Presentation thumbnail

Early predictors of in-hospital mortality in patients with acute heart failure. A general hospital experience

Doctor G. Aletras (Heraklion, GR)

Abstract Slides

Presentation thumbnail

Predictors of mortality in heart failure patients with reduced ejection fraction: neutrophil-to-lymphocyte ratio, platelets-to-lymphocyte ratio, neutrophil- percentage-to-albumin-ratio

Doctor J. Stevic (Belgrade, RS)

Abstract Slides

Presentation thumbnail

Genetic insights into cardiomyopathy: familial and histologic features of transplant-dependent failing hearts in hcmp

Doctor K. Kim (Incheon, KR)

Abstract Slides

Presentation thumbnail

Current practices and perspectives on the use of intravenous vasodilators in acute heart failure: an international survey.

Doctor A. Galluzzo (Rivoli, IT)

Abstract Slides

Access the full session

Session thumbnail

Improving outcomes in acute heart failure

The Event

Event poster

ESC Acute CardioVascular Care 2025

14 March 2025 17:20 CET

You may be interested in

Congress Session

Acute heart failure therapies: from clinical trials to clinical practice

Congress Session

Devices in acute heart failure

Congress Session

Guideline-directed medical therapy implementation in special clinical scenarios

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources